Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
GRANT OF SHARE OPTIONS
BY HUTCHISON CHINA MEDITECH LIMITED
This announcement is made pursuant to Rule 17.06A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules").
The board of directors (the "Board") of CK Hutchison Holdings Limited (the "Company") announces that on 20 April 2018, 762,690 share options were granted by Hutchison China MediTech Limited ("HCML", an approximately 60.31% held subsidiary of the Company, whose shares are traded on the AIM market of the London Stock Exchange and in the form of American Depositary Shares on the NASDAQ Global Select Market) under its share option scheme (the "HCML Scheme", which was unconditionally adopted on 13 May 2016) to certain Eligible Employees (as defined in the HCML Scheme) (the "Grantees") to subscribe for ordinary shares of nominal value of US$1 each of HCML (each a "HCML Share"). Details of such share options are as follows:
Date of grant | : 20 April 2018 |
Exercise price of share options granted | : GBP46.45 per HCML Share |
Number of share options granted | : 762,690 (each share option shall entitle |
the holder thereof to subscribe for one | |
HCML Share) |
Closing market price of the HCML Shares : GBP46.45 per HCML Share on the date of grant
Validity period of the share options : from 20 April 2018 to 19 April 2028
None of the Grantees is a director, chief executive nor substantial shareholder of HCML, or an associate (as defined under the Listing Rules) of any of them.
By Order of the Board
Edith Shih
Executive Director & Company Secretary
Hong Kong, 23 April 2018
As at the date of this announcement, the Directors of the Company are:
Executive Directors:
Mr LI Ka-shing (Chairman)
Mr LI Tzar Kuoi, Victor (Group Co-Managing Director and Deputy Chairman)
Mr FOK Kin Ning, Canning (Group Co-Managing Director)
Mr Frank John SIXT (Group Finance Director and Deputy Managing Director)
Mr IP Tak Chuen, Edmond
(Deputy Managing Director)
Mr KAM Hing Lam
(Deputy Managing Director)
Mr LAI Kai Ming, Dominic (Deputy Managing Director)
Ms Edith SHIH
Non-executive Directors: Mr CHOW Kun Chee, Roland
Mrs CHOW WOO Mo Fong, Susan
Mr LEE Yeh Kwong, Charles
Mr LEUNG Siu Hon
Mr George Colin MAGNUS
Independent Non-executive Directors: Mr KWOK Tun-li, Stanley
Mr CHENG Hoi Chuen, Vincent
The Hon Sir Michael David KADOORIE Ms LEE Wai Mun, Rose
Mr William Elkin MOCATTA (Alternate to The Hon Sir Michael David Kadoorie)
Mr William SHURNIAK
Mr WONG Chung Hin
Dr WONG Yick-ming, Rosanna
Attachments
- Original document
- Permalink
Disclaimer
CK Hutchison Holdings Limited published this content on 23 April 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 23 April 2018 12:31:02 UTC